Cure of metastatic melanoma with surgery, low-dose methotrexate and heparin: A case report [1]

Melanoma Research

Volumn 14, Issue 5, 2004, Pages 425-

  Sampsel, James W ^a,b   Macivor, Malcolm ^a   Barbera Guillem, Emilio ^a  

^a Memorial Hospital of Union County   (United States)

^b Box 395 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; METHOTREXATE;

ADULT; ANAMNESIS; CANCER GROWTH; CANCER SURGERY; CASE REPORT; CLINICAL FEATURE; FEMALE; FEMORAL ARTERY; HUMAN; ILIAC ARTERY; LETTER; MEDICAL EXAMINATION; MELANOMA; METASTASIS; PRIORITY JOURNAL; SKIN GRAFT; SURVIVAL TIME; TUMOR VOLUME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HEPARIN; HUMANS; MELANOMA; METHOTREXATE; RECURRENCE; SKIN NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME;

EID: 7244250401     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-200410000-00015     Document Type: Letter

References (6)

1. Oberfield RA, Sullivan RD. Prolonged and continuous regional arterial infusion chemotherapy in patients with melanoma. J Am Med Assoc 1969; 209:75-79.
2. Menzies SW, McCarthy WH. Complete regression of primary cutaneous malignant melanoma. Arch Surg 1997; 132:553-556.
3. Nystrom ML, Steele JP, Shamash J, Neville F, Oliver RT. Low dose continuous chemotherapy for metastatic melanoma: a phase II trial. Melanoma Res 2003; 13(2):197-199.
4. Zacharski LR, Loynes JT. The heparins and cancer. Curr Opin Pulm Med 2002; 8(5):379-382.
5. Cutolo M, Sulli A, Pizzorni C, Seriolo B, Straub RH. Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis. Ann Rheum Dis 2001; 60:729-735.
6. Barbera-Guillem E, Sampsel JW. Immune-promoted tumor cell invasion and metastasis, New considerations in cancer therapy. In: Lombart-Bosch A, Felipo V (editors): New Trends in Cancer for the 21st Century. New York: Kluwer Academic/Plenum; 2002. pp. 153-173.